• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 31, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Rates of early prostate cancer continue decline after USPSTF recommendation

Bioengineer by Bioengineer
August 18, 2016
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
Ahmedin Jemal, D.V.M., Ph.D., is a strategic director for cancer occurrence at the American Cancer Society.
Ahmedin Jemal, D.V.M., Ph.D., is a strategic director for cancer occurrence at the American Cancer Society.

Incidence rates of early prostate cancer have continued to drop since the U.S. Preventive Services Task Force recommendation against routine prostate-specific antigen (PSA) testing in all men, according to an article published online by JAMA Oncology.

The USPSTF recommendation was released in draft form in 2011 and in final form in 2012. A decline in early prostate cancer incidence rates from 2011 to 2012 has been previously reported.

Ahmedin Jemal, D.V.M., Ph.D., of the American Cancer Society, Atlanta, and coauthors used a publicly available database for incidence data on invasive prostate cancer diagnosed from 2005 through 2013. The men were 50 and older and lived in 18 Surveillance, Epidemiology and End Results (SEER) registries that covered about 28 percent of the U.S. population.

From 2012 to 2013, the localized/regional-stage prostate cancer incidence rates per 100,000 men declined from 356.5 to 335.4 in men 50 to 74 and from 379.2 to 353.6 in men 75 and older, according to the study. The authors note the decrease from 2012 to 2013 was smaller than that from 2011 to 2012 (6 percent vs. 19 percent).

Previously reported findings indicate PSA testing rates decreased significantly between 2010 and 2013. Other factors that could contribute to the decline in incidence rates for early stage prostate cancer include changes in the prevalence of unknown risk factors and preventive measures.

“In conclusion, the decrease in early-stage prostate cancer incidence rates from 2011 to 2012 in men 50 years and older persisted through 2013 in SEER registries, albeit at a slower pace. Whether this pattern will lead to a future increase in the diagnosis of distant-stage disease and prostate cancer mortality requires long-term monitoring because of the slow-growing nature of this malignant neoplasm,” the research letter concludes.

###

(JAMA Oncol. Published online August 18, 2016. doi:10.1001/jamaoncol.2016.2667. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor’s Note: The article contains funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email [email protected]

Media Advisory: To contact corresponding study author Ahmedin Jemal, D.V.M., Ph.D., email David Sampson [email protected].

Media Contact

David Sampson
[email protected]
@JAMA_current

http://www.jamamedia.org

The post Rates of early prostate cancer continue decline after USPSTF recommendation appeared first on Scienmag.

Share18Tweet7Share2ShareShareShare1

Related Posts

Empowering Cancer Care in Bangladesh Through Collaboration

October 31, 2025

Immunotherapy Plus Radiotherapy in Advanced Lung Cancer

October 30, 2025

Moffitt Research Reveals Complementary Approaches to Combat Resistance to KRAS G12C Inhibitors in Lung Cancer

October 30, 2025

Mount Sinai Tisch Cancer Center Unveils Real-Time Data Integration Tool to Accelerate and Enhance Research Accuracy

October 30, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1293 shares
    Share 516 Tweet 323
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    312 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    202 shares
    Share 81 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    136 shares
    Share 54 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Fracture Characterization of Adhesive Joints: Short-Beam Test

Fracture Characterization of Adhesive Joints: Short-Beam Test

Mid-Adolescence Boosts Autistic Individuals’ Induction Skills

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.